idis Partner for life Logo (WIPO, 05/31/2012)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark idis Partner for life was filed as Figurative mark on 05/31/2012 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Series of letters in different dimensions
| Trademark form | Figurative mark |
| File reference | 1160827 |
| Register number | 2589035 |
| Countries | 
|
| Base trademark |
No. 2589035,
July 25, 2011
|
| Application date | May 31, 2012 |
| Expiration date | May 31, 2022 |
Trademark owner
IDIS House, Churchfield Road
Weybridge, Surrey KT13 8DB
GB
Weybridge, Surrey KT13 8DB
GB
Trademark representatives
200 Aldersgate
London EC1A 4HD
GB
goods and services
35
Advertising; business management; business administration;
office functions; business services; business consultancy
services; procurement of goods; procurement of medicines;
procurement, namely, purchasing of pharmaceutical products,
medicines and drugs for others; sourcing and supply of
pharmaceutical products, medicines and drugs for customers;
provision of business support; business advisory, business
management, business information and consultancy services
relating to product distribution, operations management
services, logistics, reverse logistics, supply chain, and
distribution solutions; provision of business networking
services; collection and processing of customer requirements
and data; business marketing agency services; database stock
control; compilation of information into computer databases;
compilation and provision of business information;
processing, analysis, retrieval and presentation of business
data; data processing; sales force management; retail
services and wholesale services related to the sale of
pharmaceutical preparations and substances, drugs and
medicines; information, advisory and consultancy services,
namely, business information and business advisory services
in the fields of medical devices and pharmaceuticals and
business consultancy services in the field of early access
programs and clinical trials; information, advisory and
consultancy services relating to all the aforesaid services;
including all of the aforesaid services provided online from
a computer database or the internet or delivered via online
channels
42
Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; medical and scientific research services; medical
and scientific research, namely, conducting clinical trials;
medical and scientific research, namely, managing and
conducting clinical trials for others not for business
purposes; preparation of expert scientific reports in the
fields of pharmaceutical research and clinical trials;
clinical trials services; electronic storage of customer
data including data on customer requirements; electronic
storage of information; electronic storage of data;
provision of scientific information; analysis, retrieval and
presentation of scientific data including all the aforesaid
services provided online from a computer database or the
Internet
44
Medical services; medical consultancy and advisory services
in connection with pharmaceutical preparations and
substances, drugs and medicines; provision of information on
pharmaceuticals, drugs and medicine; provision of medical
information; analysis, retrieval and presentation of medical
data including all the aforesaid services provided online
from a computer database or the Internet
45
Regulatory affairs consultancy; regulatory affairs
consultancy for the purpose of ensuring compliance with laws
and regulations pertaining to pharmaceutical products,
medicines and drugs, namely, reviewing and formulating
standards and practices, identifying government regulations
and policies impacting on pricing and reimbursement and
developing strategies to manage them, advising others on
regulatory requirements, liaising with, and making
presentations to, regulatory authorities, not including
providing mail order services featuring specialized
information relating to drugs and drug therapy; information,
advisory and consultancy services relating to all the
aforesaid services; including all the aforesaid services
provided online from a computer database or the Internet
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 10, 2022 | 2022/49 Gaz | Deletion | |
| November 13, 2015 | 2015/48 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 6, 2015 | 2015/28 Gaz | TR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 10, 2014 | 2014/42 Gaz | CN | Rejection |
| May 31, 2014 | 2014/23 Gaz | SG | Rejection |
| May 1, 2014 | 2014/18 Gaz | KR | Rejection |
| December 20, 2013 | 2014/4 Gaz | TR | Rejection |
| November 26, 2013 | 2013/48 Gaz | KR | Rejection |
| September 12, 2013 | 2013/37 Gaz | AU | Rejection |
| May 31, 2012 | 2013/21 Gaz | GB | Registration |
ID: 141160827